These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 38260737)

  • 41. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery.
    Chen C; Wang J; Sun M; Li J; Wang HD
    Biomed Pharmacother; 2022 Jan; 145():112416. PubMed ID: 34781147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
    Ke W; Afonin KA
    Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Food-derived extracellular vesicles: natural nanocarriers for active phytoconstituents in new functional food.
    Jiang Q; Wang L; Tian J; Zhang W; Cui H; Gui H; Zang Z; Li B; Si X
    Crit Rev Food Sci Nutr; 2023 Aug; ():1-21. PubMed ID: 37548408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent Progress of Extracellular Vesicle Engineering.
    Jia X; Tang J; Yao C; Yang D
    ACS Biomater Sci Eng; 2021 Sep; 7(9):4430-4438. PubMed ID: 34455789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular Vesicles and Their Mimetics: A Comparative Study of Their Pharmacological Activities and Immunogenicity Profiles.
    Chng WH; Muthuramalingam RPK; Lou CKL; New S; Neupane YR; Lee CK; Altay Benetti A; Huang C; Thoniyot P; Toh WS; Wang JW; Pastorin G
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overview of the Therapeutic Applications of Stem Cell-Derived Exosomes: A Research and Commercial Perspective.
    Heale KA; Nath SC; Rancourt DE
    Curr Protoc; 2021 Sep; 1(9):e230. PubMed ID: 34491629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery.
    Ghadami S; Dellinger K
    Front Mol Biosci; 2023; 10():1198044. PubMed ID: 37520326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges.
    Nemati M; Singh B; Mir RA; Nemati M; Babaei A; Ahmadi M; Rasmi Y; Golezani AG; Rezaie J
    Cell Commun Signal; 2022 May; 20(1):69. PubMed ID: 35606749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma.
    Hou C; Wu Q; Xu L; Cui R; Ou R; Li D; Xu Y
    Front Bioeng Biotechnol; 2022; 10():1054324. PubMed ID: 36466338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging strategies for labeling and tracking of extracellular vesicles.
    Li YJ; Wu JY; Wang JM; Hu XB; Xiang DX
    J Control Release; 2020 Dec; 328():141-159. PubMed ID: 32882270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors.
    Nelson BC; Maragh S; Ghiran IC; Jones JC; DeRose PC; Elsheikh E; Vreeland WN; Wang L
    Nanomedicine (Lond); 2020 Sep; 15(22):2149-2170. PubMed ID: 32885720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translating extracellular vesicle packaging into therapeutic applications.
    Ozkocak DC; Phan TK; Poon IKH
    Front Immunol; 2022; 13():946422. PubMed ID: 36045692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
    Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
    Cells; 2023 May; 12(10):. PubMed ID: 37408250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy.
    Tang Y; Liu X; Sun M; Xiong S; Xiao N; Li J; He X; Xie J
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinspired exosome-like therapeutics and delivery nanoplatforms.
    Lu M; Huang Y
    Biomaterials; 2020 Mar; 242():119925. PubMed ID: 32151860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in Therapeutic Applications of Extracellular Vesicles.
    Zhang Y; Dou Y; Liu Y; Di M; Bian H; Sun X; Yang Q
    Int J Nanomedicine; 2023; 18():3285-3307. PubMed ID: 37346366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.